Nusano, a physics company transforming the production of radioisotopes, and GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company specializing in developing antibody ...
(UroToday.com) The 2024 SUO annual meeting included a kidney cancer session, featuring a presentation by Dr. Eric Jonasch discussing a phase 1B/2 study of combination 177 Lu Girentuximab + ...
Dr. Scott Tagawa presented ProstACT GLOBAL, a phase III study of best SOC with or without 177 Lu-DOTA-rosopatamab (TLX591) for patients with PSMA-expressing mCRPC who experienced disease progression ...
As the magnitude of PSA decline during 177Lu-PSMA-617 therapy for mCRPC increases, the risks for radiographic progression and all-cause mortality decreases. The magnitude of PSA decline at 12 ...
An International, Prospective, Open-label, Multi-center, Randomized Phase III Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) Versus Observation to Delay Castration or Disease ...
The pivotal phase 3 ECLIPSE trial met its primary end point in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with 177 Lu-PSMA-I&T (lutetium [177Lu] zadavotide guraxetan ...
3 Classification and mechanism of action of traditional anti-angiogenic drugs Traditional anti-angiogenic drugs mainly include macromolecular monoclonal antibodies (mAbs), small molecule tyrosine ...
Numerous monoclonal antibodies that target proinflammatory cytokines or their receptors (e.g. infliximab, adalimumab, tocilizumab, belimumab, HuMax-IL-15), and cell-surface or co-stimulatory ...
Antithyroid antibodies target specific parts of the thyroid gland, including: Thyroid peroxidase (TPO). TPO is an enzyme that plays an important role in making thyroid hormones. Thyroglobulin (Tg).
Slides were blocked in 10% normal goat serum in PBS for 60 mn at room temperature in a humidified chamber and then incubated with PSMA rabbit monoclonal antibody (Cell Signaling Technology, Danvers, ...